PNC Financial Services Group’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50	Closed	-$3	–	4944
2024 Q1	$3	Hold	50	–	–	﹤0.01%	4686
2023 Q4	$2	Hold	50	–	–	﹤0.01%	4613
2023 Q3	$11	Buy	+50	New	+$11	﹤0.01%	4596